Myriad Genetics earnings were -$127.3M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. The latest MYGN earnings report on Dec 31, 2024 announced Q4 2024 earnings of -$42.5M, up 92.3% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, MYGN reported annual earnings of -$127.3M, with -51.7% growth. The next MYGN earnings date is May 5, 2025.
What were Myriad Genetics's earnings last quarter?
On MYGN's earnings call on Invalid Date, Myriad Genetics (NASDAQ: MYGN) reported Q4 2024 earnings per share (EPS) of -$0.47, up 38.24% year over year. Total MYGN earnings for the quarter were -$42.50 million. In the same quarter last year, Myriad Genetics's earnings per share (EPS) was -$0.34.
The next MYGN earnings call is Invalid Date. Add MYGN to your watchlist to be reminded of Myriad Genetics's next earnings date.
What was MYGN's earnings growth in the past year?
As of Myriad Genetics's earnings date in Invalid Date, Myriad Genetics's earnings has grown year over year. MYGN earnings in the past year totalled -$127.30 million.
Is Myriad Genetics profitable or losing money?
As of the last Myriad Genetics earnings report, Myriad Genetics is currently losing money. Myriad Genetics's net profit (also called net income) for the twelve months ending Dec 31, 2024 was -$127.30 million, a 51.65% decrease year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.